Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.620EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
V.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.149EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.413EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.107EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.41 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.142EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.166EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.11 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used